Business of Medicine
Feature
Docs push back on step therapy in Medicare Advantage
The action is part of the broader Trump administration initiative to lower the prices and out-of-pocket costs of prescription drugs.
Feature
CMS pushes ACOs to take on more risk
ACOs that only take on upside risk generally are spending more money and not generating savings, according to CMS Adminstrator Seema Verma.
Latest News
Doctors decry inaction on physician-focused APMs
So far, PTAC has sent at least 10 APMs to the CMS. To date, not a single one has been approved or even tested on a limited scale.
Feature
Compounded topicals flagged on fears of Medicare fraud, risk
In total, 547 pharmacies – nearly 23% of those that submit most of the bills to Medicare for making these creams – hit one or more of five red-...
Feature
Ranked: State of the states’ health care
Vermont’s good outcomes and low costs have the rest of the country green with envy.
Feature
Some doctors are warming to single-payer medicine
A “youth uprising” in support of a single-payer health care system at this year’s AMA House of Delegates meeting speaks to a cultural shift in the...
Latest News
CMS proposal to level E/M payments raises concerns
Dermatologists and oncologists lose under the proposal, while ob.gyns. could see their payments increased.
Feature
PhRMA spending leads health-sector lobbying efforts
Three other health entities made the lobbying Top 10 for the first half of 2018.
News
Keeping the doctor-patient relationship at the office
Feature
To tame prescription prices, HHS dips a toe into drug importation stream
Drug prices in the United States have continued to rise and more than 80% of Americans say the government should take action.
Feature
CMS targets Part B drug policy in 2019 regulatory updates
The proposal would cut add-on payments for new drugs.